After treatment with anti-CCL22 Ab, the number of F4/80+ CD11b+ total sMΦs in salivary glands of SS model mice was significantly decreased compared with that of SS model mice treated with control IgG (Figure 5B). Here, CCL22 is linked to synovial sarcoma.